Lapathoside A

CAS No. 373646-49-2

Lapathoside A( —— )

Catalog No. M32666 CAS No. 373646-49-2

Lapathoside A and vanicoside B, inhibited the promotion stages on two-stage carcinogenesis induced by TPA.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 628 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Lapathoside A
  • Note
    Research use only, not for human use.
  • Brief Description
    Lapathoside A and vanicoside B, inhibited the promotion stages on two-stage carcinogenesis induced by TPA.
  • Description
    Lapathoside A and vanicoside B, inhibited the promotion stages on two-stage carcinogenesis induced by TPA.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    373646-49-2
  • Formula Weight
    986.9
  • Molecular Formula
    C50H50O21
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • SB1317 hydrochloride...

    SB1317 is an effective inhibitor of CDK2/JAK2/FLT3 (IC50: 13/73/56 nM).

  • Dicyclo hexyl Phthal...

    Dicyclo hexyl Phthalate

  • Cyasterone

    Cyasterone, a natural EGFR inhibitor, can inhibit the growth of A549 and MGC823 cells, via regulating EGFR signaling pathway, it may be a promising anti-cancer agent.